Page last updated: 2024-08-26

bosentan anhydrous and Cholera Infantum

bosentan anhydrous has been researched along with Cholera Infantum in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Birnboeck, H; Eggers, H; Hopfgartner, G; Jonkman, JH; Meyer, J; Schmitt, R; van Marle, S; Viischer, HW; Weber, C	1

Trials

1 trial(s) available for bosentan anhydrous and Cholera Infantum

Article	Year
Multiple-dose pharmacokinetics, safety, and tolerability of bosentan, an endothelin receptor antagonist, in healthy male volunteers. Journal of clinical pharmacology, 1999, Volume: 39, Issue:7 Topics: Administration, Oral; Antihypertensive Agents; Area Under Curve; Blood Pressure; Bosentan; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Endothelin Receptor Antagonists; Gastrointestinal Diseases; Headache; Humans; Male; Metabolic Clearance Rate; Pyrimidines; Sulfonamides; Systole	1999

Article

Year

Multiple-dose pharmacokinetics, safety, and tolerability of bosentan, an endothelin receptor antagonist, in healthy male volunteers.

Journal of clinical pharmacology, 1999, Volume: 39, Issue:7

Topics: Administration, Oral; Antihypertensive Agents; Area Under Curve; Blood Pressure; Bosentan; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Endothelin Receptor Antagonists; Gastrointestinal Diseases; Headache; Humans; Male; Metabolic Clearance Rate; Pyrimidines; Sulfonamides; Systole

1999